NFKB1 and cancer: Synthetic CB1 cannabinoids have been shown to induce NF-κB-dependent secreted alkaline phosphatase (SEAP) activity, leading to the expression of EMT markers, such as E-cadherin and vimentin, in colorectal SW-629 cancer cells [6].